6533b852fe1ef96bd12aaaa3
RESEARCH PRODUCT
false
subject
0301 basic medicinePathologymedicine.medical_specialtyTraumatic brain injurybusiness.industryPoison controlmedicine.diseaseProinflammatory cytokine03 medical and health sciencesTLR2030104 developmental biology0302 clinical medicineImmune systemNeurologymedicineTumor necrosis factor alphaNeurology (clinical)Receptorbusiness030217 neurology & neurosurgeryNeuroinflammationdescription
Danger associated molecular patterns (DAMPs) are released by damaged cells and trigger neuroinflammation through activation of non-specific pattern recognition receptors (PRRs), e.g. Toll-like receptors (TLRs). Since the role of TLR 2 and 4 after traumatic brain injury (TBI) is still unclear, we examined the outcome and the expression of proinflammatory mediators after experimental TBI in Tlr2/4 / and wild-type (WT) mice. Tlr2/4 / and wild-type mice were subjected to controlled cortical injury and contusion volume and brain edema formation were assessed 24 h thereafter. Expression of inflammatory markers in brain tissue was measured by quantitative PCR 15 min, 3, 6, 12, and 24 h after controlled cortical impact (CCI). Contusion volume was significantly attenuated in Tlr2/4 / mice (29.7 ± 0.7 mm³ as compared to 33.5 ± 0.8 mm³ in WT; p<0.05) after CCI while brain edema was not affected. Only interleukin-1beta gene expression was increased after CCI in the Tlr2/4 / relative to WT mice. iNOS, TNF, IL-6, and COX-2 were similar in injured WT and Tlr2/4 / mice, while the increase in HMGB1 was attenuated at 6 h. TLR 2 and 4 are consequently shown to potentially promote secondary brain injury after experimental CCI via neuroinflammation and may therefore represent a novel therapeutic target for the treatment of TBI.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-08-30 | Frontiers in Neurology |